Biophytis
Save
–
Market cap
–
Current P/E
–
Forward P/E
About
Biophytis S. A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases.
Similar securities
Based on sector and market capitalization
Report issue